Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

CCDC86 expression + NPM1 expression

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

NPM1 mutation (42)

FLT3 mutation + NPM1 mutation (4)

FLT3-ITD mutation + NPM1 mutation (3)

FLT3‐ITD + NPM1 mutation (3)

FLT3‐ITD mutation + DNMT3A mutation + NPM1 mutation (3)

DNMT3A mutation + NPM1 mutation (2)

NPM1 mutation + DNMT3A mutation (2)

FLT3-ITD F692L + NPM1 mutation (1)

IDH2 R140Q + NPM1 mutation (1)

IDH2 mutation + NPM1 mutation (1)

NPM1 exon 11 mutation (1)

NPM1 mutation + DNMT3A mutation + KMT2D mutation (1)

NPM1 mutation + FLT3-ITD mutation + TET2 mutation + CUX1 mutation (1)

NPM1 mutation + FLT3-TKD mutation (1)

NPM1 mutation + NRAS mutation (1)

NPM1 mutation + SRSF2 mutation (1)

NPM1 mutation + SRSF2 mutation + FLT3-ITD mutation+ DNMT3A mutation + ASXL1 mutation + NRAS mutation (1)

PTPN11 mutation + NPM1 mutation (0)

NPM1 mutation (42)

FLT3 mutation + NPM1 mutation (4)

FLT3-ITD mutation + NPM1 mutation (3)

FLT3‐ITD + NPM1 mutation (3)

FLT3‐ITD mutation + DNMT3A mutation + NPM1 mutation (3)

DNMT3A mutation + NPM1 mutation (2)

NPM1 mutation + DNMT3A mutation (2)

FLT3-ITD F692L + NPM1 mutation (1)

IDH2 R140Q + NPM1 mutation (1)

IDH2 mutation + NPM1 mutation (1)

NPM1 exon 11 mutation (1)

NPM1 mutation + DNMT3A mutation + KMT2D mutation (1)

NPM1 mutation + FLT3-ITD mutation + TET2 mutation + CUX1 mutation (1)

NPM1 mutation + FLT3-TKD mutation (1)

NPM1 mutation + NRAS mutation (1)

NPM1 mutation + SRSF2 mutation (1)

NPM1 mutation + SRSF2 mutation + FLT3-ITD mutation+ DNMT3A mutation + ASXL1 mutation + NRAS mutation (1)

PTPN11 mutation + NPM1 mutation (0)

›

CCDC86 expression + NPM1 expression

Diffuse Large B Cell Lymphoma

Resistant: C3 – Early Trials

Resistant: C3 – Early Trials